Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23890
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMaurer-Schultze, B.en
dc.contributor.authorSiebert, M.en
dc.contributor.authorBassukas, I. D.en
dc.date.accessioned2015-11-24T19:36:30Z-
dc.date.available2015-11-24T19:36:30Z-
dc.identifier.issn0014-4827-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/23890-
dc.rightsDefault Licence-
dc.subjectAnimalsen
dc.subjectAutoradiographyen
dc.subjectCarbon Radioisotopesen
dc.subjectCell Cycle/*drug effectsen
dc.subjectCell Division/drug effectsen
dc.subjectDNA Replication/*drug effectsen
dc.subjectFemaleen
dc.subjectHydroxyurea/*pharmacologyen
dc.subjectKineticsen
dc.subjectLeukemia L1210/*pathologyen
dc.subjectMiceen
dc.subjectMice, Inbred Strainsen
dc.subjectThymidine/metabolismen
dc.subjectTritiumen
dc.titleAn in vivo study on the synchronizing effect of hydroxyureaen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/3335224-
heal.identifier.secondaryhttp://ac.els-cdn.com/0014482788901577/1-s2.0-0014482788901577-main.pdf?_tid=2f513bb7456d5604e612c2ee7f3bcd01&acdnat=1333701127_c277e511481dd03b1c38ceb815414595-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1988-
heal.abstractThe effect of hydroxyurea (HU; 0.5 mg/g body wt) on L 1210 ascites tumor cells has been studied using various cell kinetic methods. In contrast to the general assumption that HU blocks cells at the G1/S boundary [J. Brachet (1985) Molecular Cytology, Vol. I, p. 266, Academic Press, New York], the present results show that the cells are not held at G1/S but enter S at about the normal rate and are accumulated in early S phase due to a dose-dependent inhibiting effect of HU on DNA synthesis. Partial synchronization of the cells demonstrated by a distinct mitotic peak 10 h after HU application is not due to a G1/S block of the cells and their subsequent synchronous passage through the cycle after release from the block but is due to rather complex mechanisms of action of HU: a differential cytocidal effect and an effect on the passage of the cells through the cycle, both depending on the position of the cells throughout the cycle. HU kills S-phase cells, mainly cells in early S phase; i.e., a great portion of the cells "accumulated" in early S phase is killed by the drug, while G1-phase cells are almost not affected by the lethal effect of HU. These G1-phase cells pass through the cycle more rapidly after cessation of the HU effect. The same is true for the surviving cells accumulated in early S phase, while part of the cells in the remaining S phase are delayed in their passage through the cycle. This causes partial synchronization, since a great portion of all cells that survive HU treatment reach mitosis at the same time.en
heal.journalNameExp Cell Resen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Maurer-Schultze-1988-An in vivo study on.pdf917.86 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons